![Paul A. Hamlin, MD -- Clinical Director, Lymphoma Outpatient Unit](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/263/image/hamlin-paul.jpg?h=10d202d3)
Paul A. Hamlin, MD
Lymphoma Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Diffuse Large B-Cell Lymphoma in the Elderly
- Antibody Drug Conjugates
- Non-Hodgkin Lymphoma
Request an Appointment
About Me
- Attending Physician
I am a board-certified medical oncologist and a member of the Lymphoma Service at Memorial Sloan Kettering Cancer Center. My colleagues and I work to ensure a world-class collaborative environment, bringing medical expertise, access to cutting-edge clinical research, and specialized cancer care to our patients.
Over the last two decades, I have specialized in the care of patients with Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). During this time, I have served in many leadership positions at MSK, including Clinical Director of the Lymphoma Service, Chief of our Basking Ridge site, Acting Chief of the Lymphoma Service, and Medical Director of the David H. Koch Center for Cancer Care.
Read more
My clinical research interests have focused on developing novel therapies and dedicated treatment programs for older patients with lymphoma, addressing the complex interplay between aging and a cancer diagnosis. As part of a multidisciplinary MSK team that cares for patients aged 65 and older, we have worked to develop new treatment strategies for older patients with diffuse large B-cell lymphoma, mantle cell lymphoma, and Hodgkin lymphoma, as well as patients with chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia.
Ongoing research efforts are creating new screening tools to identify patients at an increased risk for treatment side effects and clinical trials specifically aimed at addressing the needs of the older patient population. We a shared goal of developing effective risk-adapted therapies to minimize the side effects of treatments while maximizing their effectiveness.
As a clinical researcher, I have been the principal investigator (PI) or co-PI of more than 30 clinical trials. My work continues to explore novel biologic and immunotherapeutic agents for the treatment of both NHL and Hodgkin lymphoma, with phase I and II trials focused on new antibody combinations, antibody drug conjugates, immunotoxins, and small molecule inhibitors.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
My Specialties
- Diffuse Large B-Cell Lymphoma in the Elderly
- Antibody Drug Conjugates
- Non-Hodgkin Lymphoma
- Hodgkin's Disease
- Mantle Cell Lymphoma
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Education
- MD, SUNY Health Science Center at Brooklyn
Residencies
- Internal Medicine - New York University Medical Center
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Hamlin sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Hamlin
- A Phase 2 Study of BGB-11417 in People With Waldenström's Macroglobulinemia
- A Phase II/III Study of CC-486 (Oral Azacitidine) plus Standard Therapy in Older Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
- A Pilot Study Assessing the Effects of CAR T-Cell Therapy in Elderly Patients Treated for Lymphoma
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Hamlin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Paul A. Hamlin discloses the following relationships and financial interests:
-
ADC Therapeutics
Professional Services and Activities -
Dava Oncology
Professional Services and Activities (Uncompensated)
-
Pfizer, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].